DE3370587D1 - Compositions comprising interferon and their therapeutic use - Google Patents

Compositions comprising interferon and their therapeutic use

Info

Publication number
DE3370587D1
DE3370587D1 DE8383306702T DE3370587T DE3370587D1 DE 3370587 D1 DE3370587 D1 DE 3370587D1 DE 8383306702 T DE8383306702 T DE 8383306702T DE 3370587 T DE3370587 T DE 3370587T DE 3370587 D1 DE3370587 D1 DE 3370587D1
Authority
DE
Germany
Prior art keywords
interferon
compositions
therapeutic use
hyroxymethyl
guanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383306702T
Other languages
English (en)
Inventor
Kendall O Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ens Bio Logicals Inc
Original Assignee
Ens Bio Logicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ens Bio Logicals Inc filed Critical Ens Bio Logicals Inc
Application granted granted Critical
Publication of DE3370587D1 publication Critical patent/DE3370587D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
DE8383306702T 1982-11-04 1983-11-03 Compositions comprising interferon and their therapeutic use Expired DE3370587D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/439,121 US4462986A (en) 1982-11-04 1982-11-04 Synergistic anti-herpes compositions

Publications (1)

Publication Number Publication Date
DE3370587D1 true DE3370587D1 (en) 1987-05-07

Family

ID=23743382

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383306702T Expired DE3370587D1 (en) 1982-11-04 1983-11-03 Compositions comprising interferon and their therapeutic use

Country Status (10)

Country Link
US (1) US4462986A (de)
EP (1) EP0109234B1 (de)
JP (1) JPS59130223A (de)
AT (1) ATE26216T1 (de)
AU (1) AU557894B2 (de)
CA (1) CA1239093A (de)
DE (1) DE3370587D1 (de)
HK (1) HK77989A (de)
MC (1) MC1552A1 (de)
ZA (1) ZA838179B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4636383A (en) * 1984-08-29 1987-01-13 Schering Corporation Interferon-cyclaradine combination
US4857316A (en) * 1984-10-03 1989-08-15 Syntex (U.S.A.) Inc. Synergistic antiviral composition
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
US4849412A (en) * 1986-06-05 1989-07-18 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
JP2525104B2 (ja) * 1992-03-24 1996-08-14 日本碍子株式会社 樹脂含浸紙コンデンサコアおよびその製造方法
US5550114A (en) 1993-04-02 1996-08-27 Thomas Jefferson University Epidermal growth factor inhibitor
FI973784A (fi) * 1997-09-25 1999-03-26 Huhtamaeki Oy Ksylitolikaramelli, erityisesti kovakaramelli
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
CA2460341A1 (en) * 2001-10-05 2003-04-17 Intermune, Inc. Methods of treating liver fibrosis and hepatitis c virus infection
EP1674104A1 (de) * 2004-12-24 2006-06-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Uridinderivaten als antivirale Agentien gegen Flavividae, insbesonders HCV
US20100260704A1 (en) * 2006-03-08 2010-10-14 Biomethodes Human interferon-gamma (infgamma) variants
WO2013023362A1 (zh) * 2011-08-16 2013-02-21 深圳市卫武光明生物制品有限公司 静注巨细胞病毒人免疫球蛋白及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2134292A1 (en) * 1971-04-30 1972-12-08 Inst Nat Sante Rech Med Interferon compsns - contg halo desoxyuridines rifamycine or rifampycine
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
MC1475A1 (fr) * 1981-08-11 1983-06-17 Wellcome Found Procede de preparation de derives de la purine a action anti-virale
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
EP0080032A3 (de) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmazeutische Zubereitung für die Behandlung von herpetischen Verletzungen
MC1585A1 (fr) * 1982-02-12 1985-02-22 Ens Bio Logicals Inc Procede de fabrication de compositions antivirales

Also Published As

Publication number Publication date
AU557894B2 (en) 1987-01-15
ZA838179B (en) 1985-03-27
MC1552A1 (fr) 1984-08-31
AU2068183A (en) 1984-05-10
JPS59130223A (ja) 1984-07-26
US4462986A (en) 1984-07-31
EP0109234A1 (de) 1984-05-23
HK77989A (en) 1989-10-06
CA1239093A (en) 1988-07-12
ATE26216T1 (de) 1987-04-15
EP0109234B1 (de) 1987-04-01

Similar Documents

Publication Publication Date Title
DE3370587D1 (en) Compositions comprising interferon and their therapeutic use
AU589371B2 (en) Purine derivatives and use as therapeutic agent
AU623512B2 (en) Phenyl pyrimidone derivatives, processes for their preparation, and their use therapeutic agents
ZA928832B (en) Local delivery of dipyridamole for the treatment of proliferative diseases
PL299015A1 (en) Desquamative composition for use on human skin
AP9300603A0 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
IL100195A0 (en) Use of xanthines for the preparation of a medicament having immuno suppressing activity
GR3030150T3 (en) Use of Human Interferon-Beta 2A for the preparation of medicaments
DE3277726D1 (en) Use of alkaloid derivatives for the manufacture of a medicament for the strengthening of the immune system and for the treatment of viral, bacterial and fungal infections
HK1022269A1 (en) Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections
GB8914061D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
IL98849A0 (en) (2r)-2-(di-(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use
EP0212501A3 (en) Therapeutic agent for treating hematopoietic diseases
GB8914062D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8926595D0 (en) Pharmaceutical compositions for use in the treatment herpes simplex virus infections
EP0280593A3 (en) Composition on the basis of an amino-acid and vitamins for use in cancer therapy
DE3176462D1 (en) Deazapurine nucleoside, formulations thereof, and use thereof in therapy
CY2339B1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections.
ZA893261B (en) Synergistic combinations and their use as therapeutic agents
ZW5790A1 (en) Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases
MY112888A (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases.
IL100179A0 (en) The use of carbazones as novel active ingredients in medicaments
ZA929143B (en) Agents for use in the prophylaxis and therapy of fungal infections.
AU102687S (en) Nomogram for medical use
ZA902254B (en) Use of purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DER PATENTINHABER LAUTET RICHTIG: SYNTEX (U.S.A.) INC., PALO ALTO, CALIF., US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee